Immediate and Long-term Prevention of Thromboembolism in Atrial Fibrillation (AF)

Gullov AL, Koefoed BG, Petersen P, Pedersen TS, Andersen ED, Godtfredsen J, Boysen G. Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study. Arch Intern Med 1998;158:1513-1521.

Pengo V, Zasso A, Barbero F, Banzato A, Nante G, Parissenti L, John N, Noventa F, Dalla Volta S. Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation. Am J Cardiol 1998;82: 433-437.

Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996;348:633-638.

Stroke Prevention in Atrial Fibrillation III Study Investigators. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation Study. JAMA 1998;279:1273-1277.

Laupacis A, Albers G, Dalen J, Dunn MI, Jacobson AK, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 1998;114:S579-S589.

Atrial Fibrillation Investigators. Echocardiographic predictors of stroke in patients with atrial fibrillation: A prospective study of 1066 patients from 3 clinical trials. Arch Intern Med 1998;158:1316-1320.

Hart RG, Sherman DG, Easton JD, Cairns JA. Prevention of stroke in patients with nonvalvular atrial fibrillation. Neurology 1998;51:674-681.

Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: Stroke prevention in patients with nonvalvular atrial fibrillation. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1998;51:671-673.

Hart RG. Intensity of anticoagulation to prevent stroke in patients with atrial fibrillation. Ann Intern Med 1998;128:408 (Letter).

Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994;74:236-241.

Blackshear JL, Kopecky SL, Litin SC, Safford RE, Hammill SC. Management of atrial fibrillation in adults: Prevention of thromboembolism and symptomatic treatment. Mayo Clin Proc 1996;71:150-160.

Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994;89:224-227.

Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457.

Sparks PB, Mond HG, Kalman JM, Jayaprakash S, Lewis MA, Grigg LE. Atrial fibrillation and anticoagulation in patients with permanent pacemakers: Implications for stroke prevention. Pacing Clin Electrophysiol 1998;21:1258-1267.

Stafford RS, Singer DE. Recent national patterns of warfarin use in atrial fibrillation. Circulation 1998;97:1231-1233.

Brass LM, Krumholz HM, Scinto JD, Mathur D, Radford M. Warfarin use following ischemic stroke among Medicare patients with atrial fibrillation. Arch Intern Med 1998;158:2093-2100.

Marine JE, Goldhaber SZ. Controversies surrounding long-term anticoagulation of very elderly patients in atrial fibrillation. Chest 1998;113:1115-1118.

Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: Anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998;158:1641-1647.

Seidl K, Hauer B, Schwacke H, Droegemueller A. Intrahospital stroke rates after acute electrical cardioversion in atrial fibrillation and atrial flutter despite effective anticoagulation: A prospective study. Circulation 1998;98(Suppl I):I-298.

Lanzarotti CJ, Olshansky B. Thromboembolism in chronic atrial flutter: Is the risk underestimated? J Am Coll Cardiol 1997;30:1506-1511.

Sgalambro A, Corrado G, Gentile F, Mantero A, Santarone M, Gasparini M, Bufalino R, Morabito A, Savino K, Schiavina R, Mangia R. Thromboembolic risk in atrial flutter: Preliminary results of the Italian multicenter FLASIEC study. Circulation 1998;98(Suppl I):I-703.

Seidl K, Hauer B, Schwick NG, Zellner D, Zahn R, Senges J. Risk of thromboembolic events in patients with atrial flutter. Am J Cardiol 1998;82:580-583.

Chanepa-Anson R, William M, Marshall JM, Mitsuoka T, Lightman S, Sutton R. Mechanism of polyuria and natuiresis in atrioventricular nodal tachycardia. Br Med J 1984;289:866-8.

Tsai LM, Chen JH, Tsao CJ. Relation of left atrial spontaneous echo contrast with prethrombotic state in atrial fibrillation associated with systemic hypertension, idiopathic dilated cardiomyopathy, or no identifiable cause (lone). Am J Cardiol 1998;81:1249-1252.

Sohara H, Amitani S, Kurose M, Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: A study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 1997;29:106-112.

Weigner MJ, Patel J, Thomas LR, Schwartz JG, Burger AJ, Douglas PS, Silverman DI, Manning WJ. Transesophageal echocardiography facilitated cardioversion from atrial fibrillation: Short term safety and implications regarding maintenance of sinus rhythm. Circulation 1998;98(Suppl I):I-500.

Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographic study. J Am Coll Cardiol 1995;25:452-459.

Panagiotopoulos K, Toumanidis S, Saridakis N, Vemmos K, Moulopoulos S. Left atrial and left atrial appendage functional abnormalities in patients with cardioembolic stroke in sinus rhythm and idiopathic atrial fibrillation. J Am Soc Echocardiogr 1998;11:711-719.

The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med 1998;128:639-647.

Zabalgoitia M, Halperin JL, Pearce LA, Blackshear JL, Asinger RW, Hart RG. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. J Am Coll Cardiol 1998;31: 1622-1626.

Berger M, Schweitzer P. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: A retrospective analysis. Am J Cardiol 1998;82:1545-1547.

Klein AL, Grimm RA, Black IW, Leung DY, Chung MK, Vaughn SE, Murray RD, Miller DP, Arheart KL. Cardioversion guided by transesophageal echocardiography: The ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography. Ann Intern Med 1997;126: 200-209.

Steering and Publications Committees of the ACUTE Study. Design of a clinical trial for the assessment of cardioversion using transesophageal echocardiography (The ACUTE Multicenter Study). Am J Cardiol 1998;81:877-883.

Omran H, Jung W, Rabahieh R, Schimpf R, Wolpert C, Hagendorff A, Fehske W, Luderitz B. Left atrial chamber and appendage function after internal atrial defibrillation: A prospective and serial transesophageal echocardiographic study. J Am Coll Cardiol 1997;29:131-138.